Short answer
Beauty Health Co (SKIN) filed its Q1 2026 10-Q quarterly report on May 7, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $65M (down 6.7% year over year) with net income of −$7M.
Q1 2026 key financials · XBRL
- Revenue
- $65M
- −6.7% YoY
- Net income
- −$7M
- +34.3% YoY
- Operating margin
- -2.8%
- Gross margin
- 68.5%
- EPS (diluted)
- −$0.05
- +37.5% YoY
Source: XBRL data from the Beauty Health Co (SKIN) Q1 2026 10-Q on SEC EDGAR. USD.
Beauty Health Co Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $64.9M, down 6.7% YoY from $69.6M
- Gross margin 68.5% vs 69.8% YoY, primarily due to higher amortization expense
- Consumables largest line at $46.4M, down 6.1%; Delivery Systems weakest at $18.5M, down 8.3%
- Cash, cash equivalents, and restricted cash $204.4M at March 31, 2026
- $20.2M spent repurchasing 2026 Notes; management expects sufficient liquidity for at least 12 months, with macroeconomic and credit headwinds continuing
Risk Factors
- New brand-recognition risk triggered by April 22, 2026 name change to SkinHealth Systems Inc.
- Rebranding risk: search-ranking disruption could replace free traffic with higher-cost paid traffic
- Competitive risk: intensified market competition increases dependence on successful brand differentiation
- Financial risk: rebranding expenses may not be offset by increased revenue or profitability
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Beauty Health Co quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.